Stéphane Bancel, Moderna CEO (Markus Schreiber/AP Images)
March 27, 2024 04:04 PM EDT
R&D

Here's how Mod­er­na is think­ing about the fu­ture of its vac­cines

Max Gelman

Senior Editor

Mod­er­na laid out its ex­pec­ta­tions for sev­er­al vac­cine mar­kets Wednes­day morn­ing at an in­vestor event as it con­tin­ues mov­ing through its year …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times